Okyaz Eminaga

Dr. Okyaz Eminaga

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
OEOkyaz Eminaga
Okyaz Eminaga
MAMahmoud Abbas
Mahmoud Abbas
JSJeanne Shen
Jeanne Shen
MLMark Laurie
Mark Laurie
JBJames D Brooks
James D Brooks
DRDaniel Rubin
Daniel Rubin

4 March 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
OEOkyaz Eminaga
Okyaz Eminaga
MAMahmoud Abbas
Mahmoud Abbas
CKChristian Kunder
Christian Kunder
YTYuri Tolkach
Yuri Tolkach
RHRyan Han
Ryan Han
OBOlaf Bettendorf
Olaf Bettendorf
Prostate cancer pathology plays a crucial role in clinical management but is time-consuming. Artificial intelligence (AI) shows promise in detecting prostate cancer and grading patterns. We tested an AI-based digital twin of a pathologist, vPatho, on 2603 histological images of prostate tissue stained with hematoxylin and eosin. We analyzed various factors influencing tumor grade discordance between the vPatho system and six human pathologists. Our results demonstrated that vPatho achieved comparable performance in prostate cancer detection and tumor volume estimation, as reported in the literature. The concordance levels between vPatho and human pathologists were examined. Notably, moderate to substantial agreement was observed in identifying complementary histological features such as ductal, cribriform, nerve, blood vessel, and lymphocyte infiltration. However, concordance in tumor grading decreased when applied to prostatectomy specimens (κ = 0.44) compared to biopsy cores (κ = 0.70). Adjusting the decision threshold for the secondary Gleason pattern from 5 to 10% improved the concordance level between pathologists and vPatho for tumor grading on prostatectomy specimens (κ from 0.44 to 0.64). Potential causes of grade discordance included the vertical extent of tumors toward the prostate boundary and the proportions of slides with prostate cancer. Gleason pattern 4 was particularly associated with this population. Notably, the grade according to vPatho was not specific to any of the six pathologists involved in routine clinical grading. In conclusion, our study highlights the potential utility of AI in developing a digital twin for a pathologist. This approach can help uncover limitations in AI adoption and the practical application of the current grading system for prostate cancer pathology.

6 March 2024 in npj Imaging
Verified
Journal Article
Open access
PDF file
OEOkyaz Eminaga
Okyaz Eminaga
FSFred Saad
Fred Saad
ZTZhe Tian
Zhe Tian
UWUlrich Wolffgang
Ulrich Wolffgang
PKPierre I. Karakiewicz
Pierre I. Karakiewicz
SLSami-Ramzi Leyh-Bannurah
Sami-Ramzi Leyh-Bannurah
Malignancy grading of prostate cancer (PCa) is fundamental for risk stratification, patient counseling, and treatment decision-making. Deep learning has shown potential to improve the expert consensus for tumor grading, which relies on the Gleason score/grade grouping. However, the core problem of interobserver variability for the Gleason grading system remains unresolved. We developed a novel grading system for PCa and utilized artificial intelligence (AI) and multi-institutional international datasets from 2647 PCa patients treated with radical prostatectomy with a long follow-up of ≥10 years for biochemical recurrence and cancer-specific death. Through survival analyses, we evaluated the novel grading system and showed that AI could develop a tumor grading system with four risk groups independent from and superior to the current five grade groups. Moreover, AI could develop a scoring system that reflects the risk of castration resistant PCa in men who have experienced biochemical recurrence. Thus, AI has the potential to develop an effective grading system for PCa interpretable by human experts.

22 April 2024
Verified
Journal Article
Open access
PDF file
AYAndy Wai Kan Yeung
Andy Wai Kan Yeung
OLOlena Litvinova
Olena Litvinova
Nicola Luigi BragazziNicola Luigi Bragazzi
Nicola Luigi Bragazzi
Yousef KhaderYousef Khader
Yousef Khader
Md.Mostafizur RahmanMd.Mostafizur Rahman
Md.Mostafizur Rahman
Atanas G. AtanasovAtanas G. Atanasov
Atanas G. Atanasov
Aim: This study aimed to identify and analyze the top 100 most cited digital health and mobile health (m-health) publications. It could aid researchers in the identification of promising new research avenues, additionally supporting the establishment of international scientific collaboration between interdisciplinary research groups with demonstrated achievements in the area of interest. Methods: On 30th August, 2023, the Web of Science Core Collection (WOSCC) electronic database was queried to identify the top 100 most cited digital health papers with a comprehensive search string. From the initial search, 106 papers were identified. After screening for relevance, six papers were excluded, resulting in the final list of the top 100 papers. The basic bibliographic data was directly extracted from WOSCC using its “Analyze” and “Create Citation Report” functions. The complete records of the top 100 papers were downloaded and imported into a bibliometric software called VOSviewer (version 1.6.19) to generate an author keyword map and author collaboration map. Results: The top 100 papers on digital health received a total of 49,653 citations. Over half of them (n = 55) were published during 2013–2017. Among these 100 papers, 59 were original articles, 36 were reviews, 4 were editorial materials, and 1 was a proceeding paper. All papers were written in English. The University of London and the University of California system were the most represented affiliations. The USA and the UK were the most represented countries. The Journal of Medical Internet Research was the most represented journal. Several diseases and health conditions were identified as a focus of these works, including anxiety, depression, diabetes mellitus, cardiovascular diseases, and coronavirus disease 2019 (COVID-19). Conclusions: The findings underscore key areas of focus in the field and prominent contributors, providing a roadmap for future research in digital and m-health.

26 June 2019 in Health Informatics Journal
Verified
Journal Article
Closed access
PDF file
OEOkyaz Eminaga
Okyaz Eminaga
OAOmran Al-Hamad
Omran Al-Hamad
MBMartin Boegemann
Martin Boegemann
BBBernhard Breil
Bernhard Breil
ASAxel Semjonow
Axel Semjonow
This study aims to introduce as proof of concept a combination model for classification of prostate cancer using deep learning approaches. We utilized patients with prostate cancer who underwent surgical treatment representing the various conditions of disease progression. All possible combinations of significant variables from logistic regression and correlation analyses were determined from study data sets. The combination possibility and deep learning model was developed to predict these combinations that represented clinically meaningful patient’s subgroups. The observed relative frequencies of different tumor stages and Gleason score Gls changes from biopsy to prostatectomy were available for each group. Deep learning models and seven machine learning approaches were compared for the classification performance of Gleason score changes and pT2 stage. Deep models achieved the highest F1 scores by pT2 tumors (0.849) and Gls change (0.574). Combination possibility and deep learning model is a useful decision-aided tool for prostate cancer and to group patients with prostate cancer into clinically meaningful groups.

23 April 2023 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
OEOkyaz Eminaga
Okyaz Eminaga
TLTimothy Jiyong Lee
Timothy Jiyong Lee
JGJessie Ge
Jessie Ge
ESEugene Shkolyar
Eugene Shkolyar
MLMark Laurie
Mark Laurie
JLJoseph C. Liao
Joseph C. Liao